Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients
NCT05395143Phase 2Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- May 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hyperlipidemia comparing Atorvastatin and zinc with Atorvastatin and placebo (2 arms). Primary endpoint: Total Cholesterol at 8 weeks. Status: unknown.
02
Drugs
zinc
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT05395143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05395143.